Lessons from Cardiac and Vascular Biopsies from Patients with and without Inflammatory Rheumatic Diseases

Rheum Dis Clin North Am. 2023 Feb;49(1):129-150. doi: 10.1016/j.rdc.2022.07.005.

Abstract

Feiring Heart Biopsy Study enables searching for potential pathogenetic mechanisms, therapeutic targets, and biomarkers through the assessment of clinical data and multiple blood and tissue samples from patients with and without inflammatory rheumatic diseases (IRDs), undergoing coronary artery bypass grafting. Some of our findings, for example, more inflammation (including the presence of immune cells and expression of proinflammatory cytokines) in vessels and the heart, and the presence of certain bacteria and autoantigens in vessels, could contribute to the increased risk of ischemia, aneurysms, and/or cardiac dysfunction in IRDs. Furthermore, some of the detected factors could be involved in the pathomechanisms of these conditions in general.

Keywords: Cardiovascular disease; Immune system; Infections; Inflammation; Rheumatic diseases.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biopsy
  • Cytokines
  • Humans
  • Inflammation*
  • Rheumatic Diseases*

Substances

  • Cytokines